Pheno-/genotyping [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2008-12-25 14:44 (6396 d 02:41 ago) – Posting: # 2979
Views: 5,815

Dear Rahul,

I agree with ElMaestro. Phenotyping can be done in screening by administering debrisoquine; an alternative is genotyping (poor metabolizers carrying at least one of the CYP2D6*9, CYP2D6*10, or CYP2D6*17 alleles). For details see Wikipedia.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
297 visitors (0 registered, 297 guests [including 14 identified bots]).
Forum time: 18:26 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5